$0.68
-0.06(-8.37%)
Mkt Cap $6M
$0.66
$2.95
52-Week Range
At a Glance
AI-generated6-K
Gelteq Limited received a Nasdaq notification letter on March 18, 2026, stating that its ordinary shares closed below $1.00 for 30 consecutive business days, failing Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days until September 14, 2026, to regain compliance by achieving a $1.00 closing bid price for 10 consecutive business days, with trading continuing uninterrupted under 'GELS'.$6M
Market Cap
—
Revenue
—
Net Income
Employees7
Fundamentals
How The Business Makes Money
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
Industry Drug Manufacturers - Specialty & Generic
Activity
What Changed Recently
Company Profile
CIK0001920092
ISINAU0000218109
Phone61 3 9087 3990
Address641 Glen Huntly Road, Caulfield, VIC, 3162, AU
SEC EDGAR